Multiple osteonecrosis of the jaw, oral bisphosphonate therapy and refractory rheumatoid arthritis (Pathological fracture associated with ONJ and BP use for osteoporosis)

Clinical and Experimental Rheumatology

Volumn 26, Issue 2, 2008, Pages 384-385

  Grana J ^a   Vazquez Mahia, I ^a   Sanchez Meizoso M O ^a   Vazquez T ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CHLOROQUINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GOLD SALT; LEFLUNOMIDE; METHOTREXATE; VITAMIN D;

ADULT; BONE NECROSIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ACTIVITY; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; FEMALE; HEMATURIA; HUMAN; HYPERBARIC OXYGEN; JAW FRACTURE; JAW OSTEONECROSIS; LETTER; LOW DRUG DOSE; MANDIBLE; ONSET AGE; OSTEOPOROSIS; PAIN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADMINISTRATION, ORAL; ARTHRITIS, RHEUMATOID; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; HUMANS; JAW DISEASES; MIDDLE AGED; OSTEONECROSIS; OSTEOPOROSIS;

EID: 43349085887     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. WOO SB, HELLSTEIN JW, KALMAR JR: Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 2006; 144: 753-61. Review. Erratum in: Ann Intern Med 2006; 145: 235. Comment in: Ann Intern Med 2006; 145: 791-2; author reply 792. Ann Intern Med 2006; 145: 791; author reply 792.
2. MELO MD, OBEID G: Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy. Strategies for prevention and early recognition. JADA 2005; 136: 1675-81.
3. BILEZIKIAN JP: Osteonecrosis of the jaw - Do bisphosphonates pose a risk? N Engl J Med 2006; 355: 2278-81.
4. KHAMAISI M, REGEV E, YAROM N et al.: Possible Association Between Diabetes and Bisphosphonate-Related Jaw Osteonecrosis. J Clin Endocrinol Metab 2006 Dec 19; [Epub ahead of print].
5. LENZ JH, STEINER-KRAMMER B, SCHMIDT W, FIETKAU R, MUELLER PC, GUNDLACH KK: Does avascular necrosis of the jaws in cancer patients only occur following treatment with bisphosphonates? J Craniomaxillofac Surg 2005; 33: 395-403. [Epub 2005 Oct 25].
6. HOFF AO, TOTH B, ALTUNDAG K et al.: Osteonecrosis of the jaw in patients receiving intravenous bisphosphonate therapy. J Bone Miner Res 2005; 20 (Suppl. 1): 1218 (abstract).
7. POLIZZOTTO MN, COUSINS V, SCHWARER AP: Bisphosphonate-associated osteonecrosis of the auditory canal. Br J Haematol 2006; 132: 114.
8. HINO S, MURASE R, TERAKADO N, SHINTANI S, HAMAKAWA H: Response of diffuse sclerosing osteomyelitis of the mandible to alendronate: follow-up study by Tc-99m scintigraphy. Int J Oral Maxillofacial Surg 2005; 34: 576-8.
9. CENGIZ SB, BATIRBAYGIL Y, ONUR MA et al.: Histological comparison of alendronate, calcium hydroxide and formocresol in amputated rat molar. Dental Traumatol 2005; 21: 281-8.
10. BOLLAND MJ, GREY A, REID IR: Osteonecrosis of the jaw and bisphosphonates. BMJ 2006; 333: 1122-3.